| Primary |
| Percutaneous Coronary Intervention |
65.9% |
| Anticoagulant Therapy |
4.1% |
| Acute Myocardial Infarction |
3.9% |
| Heparin-induced Thrombocytopenia |
3.6% |
| Stent Placement |
3.3% |
| Coronary Angioplasty |
2.3% |
| Coronary Artery Bypass |
2.1% |
| Acute Coronary Syndrome |
2.0% |
| Angioplasty |
2.0% |
| Peripheral Revascularisation |
1.6% |
| Antiplatelet Therapy |
1.4% |
| Catheterisation Cardiac |
1.3% |
| Arteriogram Coronary |
1.1% |
| Carotid Artery Stent Insertion |
1.0% |
| Product Used For Unknown Indication |
0.9% |
| Atrial Fibrillation |
0.8% |
| Prophylaxis |
0.8% |
| Coronary Arterial Stent Insertion |
0.7% |
| Peripheral Vascular Disorder |
0.6% |
| Therapeutic Procedure |
0.5% |
|
| Thrombosis |
15.8% |
| Thrombosis In Device |
15.6% |
| Stent Occlusion |
12.4% |
| Coronary Artery Thrombosis |
8.2% |
| Haemorrhage |
5.6% |
| Procedural Complication |
5.6% |
| Myocardial Infarction |
3.9% |
| Vascular Pseudoaneurysm |
3.8% |
| Ventricular Fibrillation |
3.6% |
| Off Label Use |
3.5% |
| Death |
3.2% |
| International Normalised Ratio Increased |
2.9% |
| Coronary Artery Occlusion |
2.7% |
| Coagulation Time Abnormal |
2.3% |
| Ventricular Tachycardia |
2.3% |
| Retroperitoneal Haemorrhage |
2.1% |
| Post Procedural Complication |
2.0% |
| Chest Pain |
1.5% |
| Drug Ineffective |
1.5% |
| Overdose |
1.5% |
|
| Secondary |
| Percutaneous Coronary Intervention |
25.3% |
| Drug Use For Unknown Indication |
17.6% |
| Product Used For Unknown Indication |
14.8% |
| Stent Placement |
5.5% |
| Myocardial Infarction |
4.5% |
| Anticoagulant Therapy |
4.3% |
| Coronary Artery Disease |
4.2% |
| Thrombosis Prophylaxis |
3.1% |
| Acute Myocardial Infarction |
3.0% |
| Angioplasty |
3.0% |
| Atrial Fibrillation |
2.5% |
| Acute Coronary Syndrome |
2.0% |
| Catheterisation Cardiac |
1.9% |
| Angina Pectoris |
1.8% |
| Arteriogram Coronary |
1.3% |
| Coronary Angioplasty |
1.1% |
| Mitral Valve Replacement |
1.1% |
| Antiplatelet Therapy |
1.0% |
| Diagnostic Procedure |
1.0% |
| Depression |
0.9% |
|
| Stent Occlusion |
9.0% |
| Thrombosis In Device |
8.5% |
| Coronary Artery Thrombosis |
8.0% |
| Vascular Pseudoaneurysm |
8.0% |
| Unresponsive To Stimuli |
7.5% |
| Thrombosis |
7.0% |
| Haemorrhage |
6.5% |
| Coronary Artery Occlusion |
6.0% |
| Thrombocytopenia |
5.5% |
| Pulmonary Haemorrhage |
5.0% |
| Subdural Haemorrhage |
4.5% |
| Post Procedural Haemorrhage |
4.0% |
| Retroperitoneal Haemorrhage |
4.0% |
| Platelet Count Decreased |
3.5% |
| Haemorrhage Intracranial |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Anaphylactic Reaction |
2.0% |
| Anaphylactic Shock |
2.0% |
| Myocardial Infarction |
2.0% |
| Pain In Extremity |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.7% |
| Product Used For Unknown Indication |
25.3% |
| Percutaneous Coronary Intervention |
7.7% |
| Stent Placement |
7.4% |
| Acute Coronary Syndrome |
3.9% |
| Acute Myocardial Infarction |
3.1% |
| Prophylaxis |
2.9% |
| Procedural Pain |
2.5% |
| Hypertension |
2.2% |
| Pain |
2.1% |
| Anticoagulant Therapy |
1.8% |
| Coronary Artery Bypass |
1.4% |
| Antiplatelet Therapy |
1.1% |
| Premedication |
1.1% |
| Arteriogram Coronary |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Coronary Arterial Stent Insertion |
0.8% |
| Vascular Graft |
0.8% |
| Coronary Angioplasty |
0.7% |
| Angina Pectoris |
0.6% |
|
| Thrombosis In Device |
41.6% |
| Death |
6.9% |
| Thrombocytopenia |
5.9% |
| Hypertensive Emergency |
5.0% |
| Device Occlusion |
4.0% |
| Injury |
4.0% |
| Coronary Artery Occlusion |
3.0% |
| Coronary Artery Thrombosis |
3.0% |
| Myocardial Infarction |
3.0% |
| Renal Failure Acute |
3.0% |
| Thrombosis |
3.0% |
| Chest Pain |
2.0% |
| Depression |
2.0% |
| Haemorrhage Intracranial |
2.0% |
| International Normalised Ratio Increased |
2.0% |
| Intracardiac Thrombus |
2.0% |
| Pain |
2.0% |
| Pelvic Haemorrhage |
2.0% |
| Platelet Count Abnormal |
2.0% |
| Pulmonary Oedema |
2.0% |
|
| Interacting |
| Catheterisation Cardiac |
50.0% |
| Agitation |
16.7% |
| Peripheral Vascular Disorder |
16.7% |
| Ventricular Fibrillation |
16.7% |
|
| Anaemia |
50.0% |
| Potentiating Drug Interaction |
50.0% |
|
